Laventair Ellipta

· GlaxoSmithKline Trading Services Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Laventair Ellipta, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: EMA Authorised: Laventair Ellipta (previously Laventair) (umeclidinium bromide;vilanterol) — GlaxoSmithKline Trading Services Limited